Open in app
Sign inGet started
Molecule and the Search for Longevity Therapeutics

Molecule and the Search for Longevity Therapeutics

In a few short weeks, we will be launching one of our flagship longevity projects with the University of Copenhagen’s Center for Healthy…
Go to the profile of Tyler Golato
Tyler Golato
Reinventing Pharma Amidst Covid-19: From Siloes to Ecosystems

Reinventing Pharma Amidst Covid-19: From Siloes to Ecosystems

We are currently facing one of the largest healthcare crises in modern history — and it’s far from over. The hunt for cures and vaccines…
Go to the profile of Paul Kohlhaas
Paul Kohlhaas
The Impact of COVID-19 on Science, Publishing, and Drug Development

The Impact of COVID-19 on Science, Publishing, and Drug Development

The Defining Event of Our Lifetimes
Go to the profile of Tyler Golato
Tyler Golato
Molecule and Arctoris announce partnership to tackle the innovation crisis in drug development.

Molecule and Arctoris announce partnership to tackle the innovation crisis in drug development.

The pharmaceutical industry is facing a wide variety of challenges, but perhaps the most pressing is the ongoing innovation crisis. Drug…
Go to the profile of Tyler Golato
Tyler Golato
Molecule dives into Ocean

Molecule dives into Ocean

Ocean Data Economy Challenge: Molecule Dataswap
Go to the profile of Benjamin Scholtz
Benjamin Scholtz
Launching Molecule Catalyst

Launching Molecule Catalyst

A decentralized platform to fund the next therapeutic breakthrough
Go to the profile of Titian Steiger
Titian Steiger
Evolution not Revolution

Evolution not Revolution

Development of the brand for the Molecule Protocol
Go to the profile of Michal Shachman
Michal Shachman
Intimidation Cancels Conversion

Intimidation Cancels Conversion

Improving the User Experience of Molecule Catalyst and Web 3.0
Go to the profile of Michal Shachman
Michal Shachman
Psychedelics on the Blockchain — Announcing the first research project to be launched on Catalyst

Psychedelics on the Blockchain — Announcing the first research project to be launched on Catalyst

TLDR; Molecule Catalyst is a crowdfunding platform for Scientific research and we are excited to introduce you to the first project that…
Go to the profile of Devon Krantz
Devon Krantz
Token Engineering in Practice: Putting Molecule Catalyst to the Test with cadCAD

Token Engineering in Practice: Putting Molecule Catalyst to the Test with cadCAD

We recently announced Molecule Catalyst and outlined more details about the technical architecture powering the system. Providing a novel…
Go to the profile of Titian Steiger
Titian Steiger
A Catalyst to Funding Research — A dive into the architecture of Molecule’s Alpha

A Catalyst to Funding Research — A dive into the architecture of Molecule’s Alpha

We recently announced the release of our first iteration of the Molecule platform, Catalyst, an initiative offering novel funding…
Go to the profile of Kent Fourie
Kent Fourie
Molecule Project Updates — 09/09

Molecule Project Updates — 09/09

Exciting new updates coming at you! The week at a glance:
Go to the profile of Devon Krantz
Devon Krantz
Introducing Molecule Catalyst

Introducing Molecule Catalyst

We’ve spent the past year developing Molecule, a software protocol that will provide a new distributed ownership structure for drug…
Go to the profile of Paul Kohlhaas
Paul Kohlhaas
Molecule Project Updates — 02/09

Molecule Project Updates — 02/09

2 September 2019
Go to the profile of Devon Krantz
Devon Krantz
Meet the Advisors

Meet the Advisors

We are proud to have assembled our first group of world-class industry experts who are collaborating with us by providing their expertise…
Go to the profile of Devon Krantz
Devon Krantz
The Molecule Vision: Why Securitise Pharmaceutical IP?

The Molecule Vision: Why Securitise Pharmaceutical IP?

Why we need a marketplace for pharmaceutical patents
Go to the profile of Liesl Eichholz
Liesl Eichholz
About Molecule BlogLatest StoriesArchiveAbout MediumTermsPrivacy